GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sihuan Pharmaceutical Holdings Group 460.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

0.79

-1.88%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥3.05bn

FY2016FY2025

Net income

CN¥209.4m

FY2016FY2025

Free cash flow

−CN¥254.1m

FY2016FY2025

Shareholders' equity

CN¥6.82bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥3.05bnCN¥1.90bnCN¥2.17bnCN¥2.54bnCN¥3.54bnCN¥2.87bnCN¥3.35bnCN¥3.40bnCN¥3.20bnCN¥3.71bn
Gross profitCN¥2.10bnCN¥1.24bnCN¥1.51bnCN¥1.73bnCN¥2.83bnCN¥2.23bnCN¥2.67bnCN¥2.77bnCN¥2.31bnCN¥2.55bn
Research and developmentCN¥381.6mCN¥504.0mCN¥689.8mCN¥1.26bnCN¥1.01bnCN¥849.6mCN¥697.9mCN¥559.6mCN¥354.1mCN¥197.3m
Operating incomeCN¥707.4m−CN¥389.4mCN¥188.4m−CN¥2.23bnCN¥899.4mCN¥917.1mCN¥1.62bnCN¥2.01bnCN¥1.71bnCN¥2.25bn
Net incomeCN¥209.4m−CN¥216.7m−CN¥62.9m−CN¥2.23bnCN¥485.3mCN¥551.5m−CN¥3.21bnCN¥1.89bnCN¥1.69bnCN¥1.99bn
Diluted earnings per share0.02-0.02-0.01-0.240.050.06-0.340.200.180.20

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥13.56bnCN¥10.53bnCN¥13.44bnCN¥14.15bnCN¥16.89bnCN¥15.20bnCN¥14.65bnCN¥17.99bnCN¥15.84bnCN¥14.20bn
Cash and short-term investmentsCN¥4.77bnCN¥3.63bnCN¥5.22bnCN¥5.58bnCN¥6.75bnCN¥5.75bnCN¥6.13bnCN¥5.38bnCN¥4.43bnCN¥4.80bn
Total liabilitiesCN¥5.52bnCN¥5.58bnCN¥7.45bnCN¥7.57bnCN¥6.23bnCN¥3.61bnCN¥3.06bnCN¥3.11bnCN¥2.63bnCN¥1.42bn
DebtCN¥1.16bnCN¥3.40bnCN¥1.18bnCN¥1.27bnCN¥1.08bnCN¥751.1mCN¥18.9mCN¥95.0m—CN¥8.3m
Shareholders' equityCN¥6.82bnCN¥4.37bnCN¥5.16bnCN¥5.52bnCN¥9.65bnCN¥10.71bnCN¥11.19bnCN¥14.58bnCN¥12.88bnCN¥12.70bn
Shares outstanding9,127m9,266m9,297m9,330m9,483m9,466m9,468m9,471m9,483m10,141m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−CN¥27.5mCN¥243.9mCN¥232.4mCN¥54.2mCN¥775.1mCN¥264.6mCN¥1.65bnCN¥2.09bnCN¥2.23bnCN¥2.35bn
Capital spending−CN¥226.6m−CN¥186.4m−CN¥344.2m−CN¥468.9m−CN¥700.3m−CN¥590.3m−CN¥583.5m−CN¥305.6m−CN¥473.4m−CN¥280.9m
Free cash flow−CN¥254.1mCN¥57.5m−CN¥111.8m−CN¥414.7mCN¥74.9m−CN¥325.7mCN¥1.07bnCN¥1.78bnCN¥1.76bnCN¥2.07bn
Dividends paid−CN¥105.9m−CN¥177.1m−CN¥347.9m−CN¥1.53bn−CN¥143.2m−CN¥1.65bn−CN¥187.6m−CN¥279.6m−CN¥1.33bn−CN¥707.3m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥1.33bnCN¥1.71bnCN¥1.34bnCN¥951.4mCN¥949.7mCN¥804.8mCN¥1.23bnCN¥835.4m
Gross profitCN¥783.3mCN¥1.22bnCN¥882.3mCN¥633.2mCN¥608.5mCN¥547.9mCN¥871.2mCN¥563.8m
Operating incomeCN¥174.2mCN¥399.3mCN¥308.0m−CN¥247.2mCN¥109.1mCN¥15.5mCN¥70.5m−CN¥711.5m
Net incomeCN¥258.2mCN¥89.8mCN¥119.5m−CN¥183.2m−CN¥33.4m−CN¥4.4m−CN¥57.8m−CN¥2.32bn
Diluted earnings per share0.030.010.01-0.02-0.00-0.00-0.01-0.25
Cash from operations—CN¥86.0m−CN¥111.0mCN¥207.0mCN¥36.0mCN¥199.0mCN¥32.0mCN¥16.0m
Capital spending—−CN¥36.0m−CN¥31.0m−CN¥22.0m−CN¥48.0m−CN¥60.0m−CN¥85.0m−CN¥42.0m
Free cash flow—CN¥50.0m−CN¥142.0mCN¥185.0m−CN¥12.0mCN¥139.0m−CN¥53.0m−CN¥26.0m
Total assetsCN¥13.55bnCN¥13.56bnCN¥12.38bnCN¥10.53bnCN¥13.43bnCN¥13.44bnCN¥13.72bnCN¥14.15bn
Cash and short-term investmentsCN¥4.33bnCN¥4.77bnCN¥4.19bnCN¥3.63bnCN¥5.67bnCN¥5.37bnCN¥5.25bnCN¥5.58bn
DebtCN¥469.5mCN¥1.16bnCN¥1.12bnCN¥900.6mCN¥1.31bnCN¥1.39bnCN¥1.51bnCN¥1.41bn
Shareholders' equityCN¥7.16bnCN¥6.82bnCN¥5.11bnCN¥4.37bnCN¥5.15bnCN¥5.16bnCN¥5.13bnCN¥5.52bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.3%1.2%-1.9%
Operating income—-5.1%-11.6%
Net income—-17.6%-21.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin67.5%68.2%72.5%73.4%
Operating margin6.4%-17.8%0.6%30.2%
Net margin-0.1%-23.8%-7.9%10.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings47.2-24.8-84.5-3.525.412.4-2.46.013.99.7
Price to sales3.22.82.53.13.52.42.33.47.35.2

Dividends and splits

Per share, in the currency the company pays

Paid for 15 years. Last went ex-dividend on 30 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.0090.0110.0210.0370.1530.0160.150.019
  • 2-for-1 split · 5 Jun 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.